NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Spryte Medical

Spryte Medical

Private
Bedford, MassachusettsHealthcare & Life Scienceshttps://sprytemedical.com/

Last Round

Strategic

Mar 25, 2026

Est. Valuation

$80.03M

Total Funding Raised

$93.45M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Spryte Medical is a medical device company developing an AI-enabled neuro Optical Coherence Tomography (nOCT) platform for intravascular imaging of the brain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

intravascular imagingnOCTneurovascular imagingoptical coherence tomographyOCTneurointerventional deviceaneurysm treatmentstroke treatmentFDA breakthrough deviceAI medical imagingendovascular treatmentmedical device consumablesinvestigational medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Spryte Medical Comps

Public and private peers based on sector, stage, and business model.

Spryte Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Spryte Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 25, 2026
M&ADec 19, 2025
SeedJun 5, 2024

Spryte Medical Investors

Notable investors and investment history

Spryte Medical investors
InvestorRounds
Development Bank of JapanStrategic
Adams Street PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    Led by Development Bank of Japan

  • Dec 19, 2025

    $49M round led by Nipro Corp.

Spryte Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Spryte Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Spryte Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersBedford, Massachusetts
Year Founded2023
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.